1. Home
  2. ACNT vs NYXH Comparison

ACNT vs NYXH Comparison

Compare ACNT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

HOLD

Current Price

$12.79

Market Cap

161.0M

Sector

Industrials

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$3.14

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNT
NYXH
Founded
1945
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Steel/Iron Ore
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.0M
190.6M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
ACNT
NYXH
Price
$12.79
$3.14
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
125.5K
56.7K
Earning Date
06-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
106.72
N/A
EPS
0.09
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$97.32
Revenue Next Year
N/A
$241.74
P/E Ratio
$143.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.62
$3.37
52 Week High
$17.92
$11.87

Technical Indicators

Market Signals
Indicator
ACNT
NYXH
Relative Strength Index (RSI) 20.15 28.09
Support Level $12.08 N/A
Resistance Level $13.06 $5.02
Average True Range (ATR) 0.60 0.27
MACD -0.44 -0.08
Stochastic Oscillator 5.81 1.47

Price Performance

Historical Comparison
ACNT
NYXH

About ACNT Ascent Industries Co.

Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: